• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,014
83
63
60
46

COUNTRY

58
19
10
7
5

CATEGORIES

  • 85
  • 124
  • 66
  • 65
  • 37
  • 37
  • 12
  • 12
  • 11
  • 18

PRICE

142
607
1,004
2,731

PUBLISHED

7
58
614
2,731

PRODUCT TYPE

2,619
90
12
7
1

Oncology

(2,731 Products)

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Skin Cancer Global Clinical Trials Review, H1, 2014

Skin Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Skin Cancer Global Clinical Trials Review, H1, 2014" provides data on the Skin Cancer clinical trial scenario....

May 2014
FROM

Small Intestine Cancer Global Clinical Trials Review, H1, 2014

Small Intestine Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Small Intestine Cancer Global Clinical Trials Review, H1, 2014" provides data on the Small Intestine...

May 2014
FROM

Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1,...

May 2014
FROM

Global Non-Melanoma Skin Cancer Market 2014-2018

About Non-melanoma Skin Cancer Non-melanoma skin cancer is one of the most common types of cancer in the world It develops in the upper layers of the skin, but not in melanocytes There are two types...

May 2014
FROM

Cancer Treatment Drugs Markets in China

China's demand for Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic...

May 2014
FROM

T-Cell Leukemia Global Clinical Trials Review, H1, 2014

T-Cell Leukemia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the T-Cell Leukemia clinical trial...

May 2014
FROM

Recurrent Malignant Glioma - Pipeline Review, H1 2014

Recurrent Malignant Glioma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H1 2014’, provides an overview of the Recurrent Malignant Glioma’s...

May 2014
FROM

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials...

May 2014
FROM

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent)...

May 2014
FROM

T-Cell Lymphomas Global Clinical Trials Review, H1, 2014

T-Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the T-Cell Lymphomas clinical...

May 2014
FROM

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014’, provides an overview...

May 2014
FROM

Uveal Melanoma - Pipeline Review, H1 2014

Uveal Melanoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H1 2014’, provides an overview of the Uveal Melanoma’s therapeutic pipeline. This report...

May 2014
FROM

Acute Promyelocytic Leukemia - Pipeline Review, H1 2014

Acute Promyelocytic Leukemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Promyelocytic Leukemia - Pipeline Review, H1 2014’, provides an overview of the Acute Promyelocytic...

May 2014
FROM

Mycosis Fungoides - Pipeline Review, H1 2014

Mycosis Fungoides - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mycosis Fungoides - Pipeline Review, H1 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. This...

May 2014
FROM

Retinoblastoma - Pipeline Review, H1 2014

Retinoblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Retinoblastoma - Pipeline Review, H1 2014’, provides an overview of the Retinoblastoma’s therapeutic pipeline. This report...

May 2014
FROM

Germ Cell Tumors - Pipeline Review, H1 2014

Germ Cell Tumors - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Germ Cell Tumors - Pipeline Review, H1 2014’, provides an overview of the Germ Cell Tumors’s therapeutic pipeline. This...

May 2014
FROM

Pancreatic Cancer - Pipeline Review, H1 2014

Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This...

May 2014
FROM

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

"Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options" provides in-depth analysis of breast cancer market within the Asia-Pacific...

May 2014
FROM

Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies

The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carboplatin and paclitaxel, which are used in combination for the treatment of platinum-sensitive disease...

May 2014
FROM

EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023

EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023 Summary Non-Hodgkin's lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system In NHL, the body's immune...

May 2014
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)